Erianin inhibits the progression of triple-negative breast cancer by suppressing SRC-mediated cholesterol metabolism

Erianin inhibits the progression of triple-negative breast cancer by suppressing SRC-mediated cholesterol metabolism

Abstract Triple-negative breast cancer (TNBC) is highly malignant and lacks effective biotherapeutic targets. The development of efficient anticancer drugs with low toxicity and few side effects is a hotspot in TNBC treatment research. Although erianin is known to have potent antitumor activity, its...

Full description

Bibliographic Details
Main Authors: Ming Li, Shiyao Kang, Xuming Deng, Huimin Li, Yuan Zhao, Wenru Tang, Miaomiao Sheng
Format: Article
Language:English
Published: BMC 2024-05-01
Series:Cancer Cell International
Subjects:
Erianin
TNBC
SRC
Cholesterol levels
Molecular mechanism
Online Access:https://doi.org/10.1186/s12935-024-03332-2

Internet

https://doi.org/10.1186/s12935-024-03332-2

Similar Items